Yildirim SF, Demir P, Kosku H, Yalcin B, et al. Clinical impact of ENIGMA-based variant reclassification on genotype-phenotype
analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. Breast Cancer 2026;33:1329-1339.
PMID: 42789170
|